Annual Total Liabilities
$165.94 M
-$78.34 M-32.07%
December 31, 2023
Summary
- As of February 26, 2025, FBIO annual total liabilities is $165.94 million, with the most recent change of -$78.34 million (-32.07%) on December 31, 2023.
- During the last 3 years, FBIO annual total liabilities has risen by +$29.52 million (+21.64%).
- FBIO annual total liabilities is now -32.07% below its all-time high of $244.28 million, reached on December 31, 2022.
Performance
FBIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$139.82 M
-$20.46 M-12.76%
September 30, 2024
Summary
- As of February 26, 2025, FBIO quarterly total liabilities is $139.82 million, with the most recent change of -$20.46 million (-12.76%) on September 30, 2024.
- Over the past year, FBIO quarterly total liabilities has dropped by -$23.97 million (-14.63%).
- FBIO quarterly total liabilities is now -42.76% below its all-time high of $244.28 million, reached on December 31, 2022.
Performance
FBIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FBIO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.1% | -14.6% |
| 3 y3 years | +21.6% | -18.1% |
| 5 y5 years | +36.9% | +16.8% |
FBIO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.1% | at low | -42.8% | at low |
| 5 y | 5-year | -32.1% | +21.6% | -42.8% | +16.8% |
| alltime | all time | -32.1% | +3810.9% | -42.8% | +3195.4% |
Fortress Biotech Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $139.82 M(-12.8%) |
| Jun 2024 | - | $160.28 M(-4.9%) |
| Mar 2024 | - | $168.58 M(+1.6%) |
| Dec 2023 | $165.94 M(-32.1%) | $165.94 M(+1.3%) |
| Sep 2023 | - | $163.79 M(-16.7%) |
| Jun 2023 | - | $196.66 M(-19.3%) |
| Mar 2023 | - | $243.75 M(-0.2%) |
| Dec 2022 | $244.28 M(+43.2%) | $244.28 M(+9.9%) |
| Sep 2022 | - | $222.21 M(+2.8%) |
| Jun 2022 | - | $216.25 M(+0.9%) |
| Mar 2022 | - | $214.35 M(+25.6%) |
| Dec 2021 | $170.63 M(+25.1%) | $170.63 M(-12.7%) |
| Sep 2021 | - | $195.37 M(+15.0%) |
| Jun 2021 | - | $169.86 M(+15.7%) |
| Mar 2021 | - | $146.82 M(+7.6%) |
| Dec 2020 | $136.41 M(-11.4%) | $136.41 M(+13.9%) |
| Sep 2020 | - | $119.73 M(-21.1%) |
| Jun 2020 | - | $151.72 M(-1.1%) |
| Mar 2020 | - | $153.47 M(-0.3%) |
| Dec 2019 | $153.89 M(+26.9%) | $153.89 M(+5.0%) |
| Sep 2019 | - | $146.59 M(+6.7%) |
| Jun 2019 | - | $137.44 M(-8.3%) |
| Mar 2019 | - | $149.83 M(+23.6%) |
| Dec 2018 | $121.25 M | $121.25 M(-13.6%) |
| Sep 2018 | - | $140.28 M(-0.2%) |
| Jun 2018 | - | $140.60 M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $157.53 M(+25.6%) |
| Dec 2017 | $125.45 M(+42.9%) | $125.45 M(+1.3%) |
| Sep 2017 | - | $123.83 M(+24.8%) |
| Jun 2017 | - | $99.23 M(+15.9%) |
| Mar 2017 | - | $85.59 M(-2.5%) |
| Dec 2016 | $87.76 M(+155.6%) | $87.76 M(+24.3%) |
| Sep 2016 | - | $70.58 M(+77.1%) |
| Jun 2016 | - | $39.85 M(+17.2%) |
| Mar 2016 | - | $34.00 M(-1.0%) |
| Dec 2015 | $34.34 M(+82.6%) | $34.34 M(+7.5%) |
| Sep 2015 | - | $31.94 M(+12.1%) |
| Jun 2015 | - | $28.49 M(-5.9%) |
| Mar 2015 | - | $30.26 M(+61.0%) |
| Dec 2014 | $18.80 M(-2.6%) | $18.80 M(+0.3%) |
| Sep 2014 | - | $18.75 M(+1.3%) |
| Jun 2014 | - | $18.50 M(-4.7%) |
| Mar 2014 | - | $19.41 M(+0.5%) |
| Dec 2013 | $19.30 M(+1.8%) | $19.30 M(-1.5%) |
| Sep 2013 | - | $19.59 M(-3.1%) |
| Jun 2013 | - | $20.22 M(+8.0%) |
| Mar 2013 | - | $18.73 M(-1.2%) |
| Dec 2012 | $18.96 M(+346.8%) | $18.96 M(+0.0%) |
| Sep 2012 | - | $18.96 M(+305.4%) |
| Jun 2012 | - | $4.68 M(+1.8%) |
| Mar 2012 | - | $4.59 M(+8.2%) |
| Dec 2011 | $4.24 M | $4.24 M(-94.1%) |
| Sep 2011 | - | $71.45 M |
FAQ
- What is Fortress Biotech annual total liabilities?
- What is the all time high annual total liabilities for Fortress Biotech?
- What is Fortress Biotech annual total liabilities year-on-year change?
- What is Fortress Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for Fortress Biotech?
- What is Fortress Biotech quarterly total liabilities year-on-year change?
What is Fortress Biotech annual total liabilities?
The current annual total liabilities of FBIO is $165.94 M
What is the all time high annual total liabilities for Fortress Biotech?
Fortress Biotech all-time high annual total liabilities is $244.28 M
What is Fortress Biotech annual total liabilities year-on-year change?
Over the past year, FBIO annual total liabilities has changed by -$78.34 M (-32.07%)
What is Fortress Biotech quarterly total liabilities?
The current quarterly total liabilities of FBIO is $139.82 M
What is the all time high quarterly total liabilities for Fortress Biotech?
Fortress Biotech all-time high quarterly total liabilities is $244.28 M
What is Fortress Biotech quarterly total liabilities year-on-year change?
Over the past year, FBIO quarterly total liabilities has changed by -$23.97 M (-14.63%)